Ophthalmic Consultants of Long Island, a group of 26 physicians based in and around New York City, announced it will be among 14 initial sites across the country surgically implanting an ocular telescope device in elderly patients suffering from age-related macular degeneration.
The pea-sized device is implanted behind the iris of one eye. The FDA-approved procedure does not reverse AMD, but may improve vision for those who are legally blind from the condition.
Candidates for the surgery are 75 and older with irreversible end-stage AMD and are no longer candidates for drug-based treatment. They must have vision ranging between 10/160 and 20/800, and may not have undergone cataract surgery in the eye in which the device would be implanted.
10 Milestones for Ambulatory Surgery Centers
3 Reasons LASIK Surgery is More Popular in the Winter
The pea-sized device is implanted behind the iris of one eye. The FDA-approved procedure does not reverse AMD, but may improve vision for those who are legally blind from the condition.
Candidates for the surgery are 75 and older with irreversible end-stage AMD and are no longer candidates for drug-based treatment. They must have vision ranging between 10/160 and 20/800, and may not have undergone cataract surgery in the eye in which the device would be implanted.
More Articles on Eye Surgery:
Glaucoma Drug Latanoprostene Bunod Enters Trial Phase 310 Milestones for Ambulatory Surgery Centers
3 Reasons LASIK Surgery is More Popular in the Winter